Celgene Corporation (NASDAQ:CELG)’s shares declined 0.19% to $147.04. Celgene International Sàrl, a wholly-owned subsidiary of CELG, on May 14 announced more than 65 abstracts reporting on investigational studies in blood and solid tumor cancers will be presented during the 50th American Society of Clinical Oncology meeting in Chicago, Ill. from May 30 to June 3, 2014. Celgene Corporation (NASDAQ:CELG) net profit margin is 19.90% and weekly performance is -2.09%. On last trading day company shares ended up $147.38. Analysts mean target price for the company is $191.67. Celgene Corporation (NASDAQ:CELG) distance from 50-day simple moving average (SMA50) is 0.89%.
AbbVie Inc (NYSE:ABBV) has named Michael Severino, M.D. its new Executive Vice President, Research and Development (R&D) and Chief Scientific Officer. Dr. Severino’s track record of innovation within the biotech industry aligns with AbbVie’s vision as a new biopharmaceutical leader with a rapidly emerging pipeline. Dr. Severino’s responsibilities include leading the R&D, Medical Affairs and Regulatory Affairs organizations at AbbVie. Globally, AbbVie has more than 7,000 people in the collective scientific organization dedicated to discovering and developing a steady stream of new medicines for patients. Severino will bring insights and expertise from his career spanning genomics and development within the biotech industry. AbbVie Inc (NYSE:ABBV) shares advanced 2.23 % in last trading session and ended the day on $54.11. Gross Margin is 76.20% and its return on assets is 14.70 %. AbbVie Inc (NYSE:ABBV) quarterly performance is 6.10 %.
MediciNova, Inc. (NASDAQ:MNOV) a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), announced the appointment of Mr. Yoshio Ishizaka to its Board of Directors. Mr. Ishizaka complements the MediciNova Board with 50 years of experience in marketing and product development with Toyota Motor Corporation (TMC). His international experience includes assignments in Japan, Europe and the U.S. MediciNova, Inc. (NASDAQ:MNOV) shares moved up 0.06% in last trading session and was closed at $1.85, while trading in range of $1.84 – $1.87. MediciNova, Inc. (NASDAQ:MNOV) year to date (YTD) performance is -13.55%.
Gilead Sciences, Inc. (NASDAQ:GILD) will be webcast corporate presentation from the 2014 UBS Healthcare Conference in New York. Robin Washington, Gilead’s Executive Vice President and Chief Financial Officer, will provide an overview of the company at the conference on Tuesday, May 20 at 10:00 a.m. Eastern Time. Gilead Sciences, Inc. (NASDAQ:GILD) ended the last trading day at $82.05. Company weekly volatility is calculated as 1.98% and price to cash ratio as 18.37. Gilead Sciences, Inc. (NASDAQ:GILD) showed a positive weekly performance of 2.12%.
Sebring Software, Inc. (OTCMKTS:SMXI) a growing Dental Practice Management (“DPM”) company with operations in Arizona and Florida, reports that three of its board members have invested a total of $1.4 million in equity over the past four months. Sebring Software Inc (OTCMKTS:SMXI) On last trading day company shares ended up $0.310.
Leave a Reply